查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1159431

鼻腔给药的全球市场(2022年～2028年)

Nasal Drug Delivery Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

全球鼻腔给药的市场规模在预测期间内预计将以5.5％的年复合成长率成长。推动市场成长的主要因素有气喘和慢性阻塞性肺病（COPD）的盛行率上升等。

本报告提供全球鼻腔给药市场调查，提供市场概要，市场的推动因素与阻碍因素的分析，市场机会，各市场区隔，各地区的市场分析，主要企业的简介等系统性资讯。

目录

第1章 报告概要

第2章 市场概要与洞察

  • 调查范围
  • 分析师的洞察和目前市场趋势

第3章 竞争情形

  • 3M Co.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • APTARGROUP, INC.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • AstraZeneca
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • Becton, Dickinson and Co.
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • Merck KGaA
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的趋势
  • 主要策略分析
  • COVID-19对主要企业带来的影响

第4章 市场区隔

  • 各剂型
    • 凝胶
    • 喷雾
    • 水滴和液体
    • 其他(粉末)
  • 容器别
    • 非加压容器
    • 加压容器
  • 各治疗用途
    • 鼻炎
    • 鼻子堵塞
    • 气喘
    • 其他(疫苗接种)
  • 各终端用户
    • 医院
    • 居家医疗

第5章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 全球其他地区

第6章 企业简介

  • Consort Medical plc
  • DTR Medical Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GlaxoSmithKline plc.
  • GoFire, Inc
  • Herantis Pharma Plc
  • Hikma Pharmaceuticals PLC
  • H&T Presspart Manufacturing Ltd.
  • Johnson & Johnson Services, Inc.
  • Nanoform Finland Oyj
  • Nemera Services
  • Neurelis, Inc.
  • Novartis International AG
  • Olympus Corp.
  • Pfizer Inc.
  • Premier Inc.
  • Sanofi S.A
  • Summit Medical LLC
  • Teleflex Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group Ltd
Product Code: OMR2026602

Global Nasal Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Gels, Sprays, Drops and Liquids, and Others), by Containers (Non-Pressurized Containers, and Pressurized Containers), by Therapeutic Application (Rhinitis, Nasal Congestion, Asthma, and Others) and by End-User (Hospitals, and Home Health Care) Forecast Period (2022-2028)

The global nasal drug delivery market is anticipated to grow at a substantial CAGR of 5.5% during the forecast period. The rising prevalence of Asthma and chronic obstructive pulmonary disease (COPD) are factors that are driving the market growth. Increasing patients pool of asthma and COPD across the globe are factors that increase the demand for nasal drugs for the treatment of diseases in the market. For instance, the report published by the Asthma and Allergy Foundation of America (AAFA), in May 2021, stated that approximately 25 million people alone in the US are suffering from asthma that is equal to 1 in 13 people aged 18 and older are living with asthma. Asthma rates are highest in black adults in the US in comparison with white adults.

The nasal drug delivery is segmented on the basis of dosage form, containers, therapeutic application, and end-user. Based on dosage form, the market is segmented into gels, sprays, drops and liquids, and others. On the basis of containers, the market is sub-divided into non-pressurized containers and pressurized containers. On the basis of therapeutic application, the market is sub-divided rhinitis, nasal congestion, asthma, and others. Furthermore, based on end-user, the market is sub-classified into hospitals and home health care. Among the end-user segment hospital segments are holding a prominent share owing to an increased number of patients pool administered in hospitals for the treatment of various diseases such as asthma, COPD, and others.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds a prominent share in the market owing to the increasing prevalence of asthma and chronic obstructive pulmonary disease and the rising adoption of technology-based treatment at procedures at an early stage. Furthermore, several technological advancements and growing product launches and innovations by key industry players in the market. For instance, in April 2019, Aptar Pharma, a new Bidose nasal spray device was approved by the US Food Drug Administration (FDA), for breakthrough therapy in the field of depression. This new Bidose liquid system intuitive and easy-to-use device with 360° functionality and precise spray characteristics and provides two-shot nasal drug delivery. Moreover, the growing number of individuals affected with asthma is such factor that is contributing to the North American region's market growth.

The competitive landscape includes key strategies of leading players, recent developments, and key company analysis. The major players that contribute to the growth of the market include 3M Co., APTARGROUP INC., AstraZeneca, Becton Dickinson and Co., Johnson & Johnson Service Inc., Merck KGaA, Novartis International AG, and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2021, Nanoform Finland Plc and Herantis Pharma Plc entered into an agreement for the formulation of Proof of Concept projects (PoCs) that aims to enhance nasal drug delivery to the brain. Both the companies in collaboration stated to develop a formulation that increases penetration into the brain via the nasal drug delivery route for CDNF.

Research Methodology

The market study of the global nasal drug delivery market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Nasal Drug Delivery Market Research And Analysis By Dosage Form

2. Global Nasal Drug Delivery Market Research And Analysis By Containers

3. Global Nasal Drug Delivery Market Research and Analysis by Therapeutic Application

4. Global Nasal Drug Delivery Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive Research Methodology of the global nasal drug delivery market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global nasal drug delivery market.
  • Insights about market determinants that are stimulating the global nasal drug delivery market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Nasal Drug Delivery Market
  • Recovery Scenario of Global Nasal Drug Delivery Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. 3M Co.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. APTARGROUP, INC.,
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. AstraZeneca
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Becton, Dickinson and Co.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Merck KGaA
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Nasal Drug Delivery Market by Dosage Form
    • 4.1.1. Gels
    • 4.1.2. Sprays
    • 4.1.3. Drops and Liquids
    • 4.1.4. Other (Powders)
  • 4.2. Global Nasal Drug Delivery Market by Containers
    • 4.2.1. Non-Pressurized Containers
    • 4.2.2. Pressurized Containers
  • 4.3. Global Nasal Drug Delivery Market by Therapeutic Application
    • 4.3.1. Rhinitis
    • 4.3.2. Nasal Congestion
    • 4.3.3. Asthma
    • 4.3.4. Others (Vaccination)
  • 4.4. Global Nasal Drug Delivery Market by End-User
    • 4.4.1. Hospitals
    • 4.4.2. Home Health Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

 

6. Company Profiles

  • 6.1. Consort Medical plc
  • 6.2. DTR Medical Ltd.
  • 6.3. Glenmark Pharmaceuticals Ltd.
  • 6.4. GlaxoSmithKline plc.
  • 6.5. GoFire, Inc
  • 6.6. Herantis Pharma Plc
  • 6.7. Hikma Pharmaceuticals PLC
  • 6.8. H&T Presspart Manufacturing Ltd.
  • 6.9. Johnson & Johnson Services, Inc.
  • 6.10. Nanoform Finland Oyj
  • 6.11. Nemera Services
  • 6.12. Neurelis, Inc.
  • 6.13. Novartis International AG
  • 6.14. Olympus Corp.
  • 6.15. Pfizer Inc.
  • 6.16. Premier Inc.
  • 6.17. Sanofi S.A
  • 6.18. Summit Medical LLC
  • 6.19. Teleflex Inc.
  • 6.20. Teva Pharmaceutical Industries Ltd.
  • 6.21. Vectura Group Ltd

LIST OF TABLES

  • 1. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 2. GLOBAL GELS NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)

3. GLOBAL SPRAY NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

4. GLOBAL DROPS AND LIQUIDS NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

5. GLOBAL OTHERS NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($MILLION)

  • 6. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 7. GLOBAL NASAL DRUG DELIVERY BY NON-PRESSURIZED CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL NASAL DRUG DELIVERY BY PRESSURIZED CONTAINERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 10. GLOBAL NASAL DRUG DELIVERY IN RHINITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL NASAL DRUG DELIVERY IN NASAL CONGESTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL NASAL DRUG DELIVERY IN ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL NASAL DRUG DELIVERY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. GLOBAL NASAL DRUG DELIVERY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL NASAL DRUG DELIVERY FOR HOME HEALTH CARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 17. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 22. EUROPEAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 23. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 24. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 25. EUROPEAN NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 26. EUROPEAN NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
  • 29. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 30. ASIA-PACIFIC NASAL DRUG DELIVERYMARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION, 2021-2028 ($ MILLION)
  • 31. ASIA-PACIFIC NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY DOSAGE FORMS, 2021-2028 ($ MILLION)
  • 34. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY CONTAINERS, 2021-2028 ($ MILLION)
  • 35. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC APPLICATION,2021-2028 ($ MILLION)
  • 36. REST OF THE WORLD NASAL DRUG DELIVERY MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)

 

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL NASAL DRUG DELIVERY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL NASAL DRUG DELIVERY MARKET, 2021-2028 (%)
  • 4. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY DOSAGE FORM, 2021 VS 2028 (%)
  • 5. GLOBAL GELS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL SPRAYS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL DROPS AND LIQUIDS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL OTHERS NASAL DRUG DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY CONTAINERS, 2021 VS 2028 (%)
  • 10. GLOBAL NASAL DRUG DELIVERY BY NON-PRESSURIZED CONTAINERS MARKET SHARE BY CONTAINERS, 2021 VS 2028 (%)
  • 11. GLOBAL NASAL DRUG DELIVERY BY PRESSURIZED CONTAINERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY THERAPEUTIC APPLICATION, 2021 VS 2028 (%)
  • 13. GLOBAL NASAL DRUG DELIVERY IN RHINITIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL NASAL DRUG DELIVERY IN NASAL CONGESTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL NASAL DRUG DELIVERY IN ASTHMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL NASAL DRUG DELIVERY IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 17. GLOBAL NASAL DRUG DELIVERY MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 18. GLOBAL NASAL DRUG DELIVERY FOR HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL NASAL DRUG DELIVERY FOR HOME HEALTH CARE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD NASAL DRUG DELIVERY MARKET SIZE, 2021-2028 ($ MILLION)